Analyst consensus rating
RxSight Analyst Rating: Hold
RXST is rated Hold by 8 analysts with a $7.79 target. As of 2026-08-23.
Direct answer
RxSight's consensus rating is Hold.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.79.
Forecast evidence checked August 23, 2026.
Get free RxSight email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.25
- Average price target
- $7.79
- High price target
- $11.00
- Low price target
- $6.00
- Low target gap
- -4%
- Target upside
- +24.6%
- High target gap
- +76%
- Target range width
- 80%
- Consensus rating
- Hold
- Analysts
- 8
- Evidence date
- August 23, 2026
- Valid through
- August 30, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for RxSight?
RxSight has a verified Hold consensus. The same dataset has an average price target of $7.79.
How far are RxSight's low and high targets from the recorded price?
The low target implies -4%, while the high target implies +76%.
How many analysts are included in RxSight's consensus?
The verified consensus includes 8 analysts.
How is RxSight's target upside or downside calculated?
The average target of $7.79 is divided by the recorded price of $6.25, then one is subtracted to produce +24.6%. This does not guarantee a future return.
When was RxSight's analyst forecast verified?
The data was verified on 2026-08-23. The dataset is valid through 2026-08-30.